Showing results (1351-1360 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|May 4, 2026
ELAVL1 increases macrophage M1 polarization via upregulating S100A8 to promote Crohn's disease progressionLin Jia, Yingtai Chen, Ying LuImmunotherapy|May 13, 2014
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis preventionSusanna Esposito, Luca Castellazzi, Annalisa Bosco, et al.Immunotherapy|November 22, 2016
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosisUyanga Batbold, Dmytro O Butov, Galyna A Kutsyna, et al.Immunotherapy|March 15, 2011
Antibody-targeted nanoparticles for cancer therapyFrancois Fay, Christopher J ScottImmunotherapy|July 13, 2026
The long-term effectiveness of specific immunotherapy in cat allergy: a real-life studyNilay Orak Akbay, Dilşad Mungan, Betül Ayşe SinImmunotherapy|July 6, 2026
Utility of serum Krebs von den Lungen-6 and surfactant protein D levels for differential diagnosis of immune checkpoint inhibitor-related pneumonitisShogo Nakai, Masato Karayama, Yusuke Inoue, et al.Immunotherapy|December 7, 2022
Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanomaBeatrix Ványai, Yi-Che Chang Chien, Lívia Beke, et al.Immunotherapy|December 13, 2022
Plain language summary of the VOLTAIRE-CD study in people with moderate-to-severe active Crohn's diseaseStephen HanauerImmunotherapy|October 13, 2020
Clinical and biological activity of rituximab in the treatment of pemphigusGérôme Bohelay, Frédéric Caux, Philippe MusetteImmunotherapy|October 13, 2020
From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancerRosa Tambaro, Marilena Di Napoli, Carmela Pisano, et al.Pageof 188